SAB Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SAB Pharma
Largest movements
- Receivables within one year -€60,496
down €60,496 (-58.5%), from €103,462 to €42,966
of which Other amounts receivable: -€74,051
- Financial fixed assets +€15,000
new in 2025: €15,000
- Cash +€6,963
up €6,963 (+33.9%), from €20,530 to €27,493
mainly Receivables within one year (+€60,496) and Net result for the year (+€19,532)
- Tangible fixed assets -€2,627
down €2,627 (-11.6%), from €22,679 to €20,052
- Other debts -€45,116
down €45,116 (-53.6%), from €84,181 to €39,065
- Debts after one year -€6,713
down €6,713 (-38.9%), from €17,276 to €10,563
- Current portion of long-term debt +€6,180
up €6,180 (+95.7%), from €6,461 to €12,641
- Tax, wage and social debts +€6,123
up €6,123 (+112.3%), from €5,450 to €11,572
of which Taxes: +€6,123
- Gross operating margin +€11,450
up €11,450 (+42.3%), from €27,063 to €38,513
- Taxes +€2,407
up €2,407 (+68.6%), from €3,509 to €5,916
- Other operating charges -€1,725
down €1,725 (-73.5%), from €2,346 to €621
- Depreciation +€1,234
up €1,234 (+12.7%), from €9,740 to €10,974
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €147,252 | €106,135 | -€41,118 | -27.9% |
| Fixed assets | 21/28 | €22,679 | €35,052 | +€12,373 | +54.6% |
| Tangible fixed assets | 22/27 | €22,679 | €20,052 | -€2,627 | -11.6% |
| Furniture and vehicles | 24 | €22,679 | €20,052 | -€2,627 | -11.6% |
| Financial fixed assets | 28 | - | €15,000 | +€15,000 | |
| Current assets | 29/58 | €124,573 | €71,083 | -€53,490 | -42.9% |
| Amounts receivable within one year | 40/41 | €103,462 | €42,966 | -€60,496 | -58.5% |
| Trade receivables | 40 | €29,411 | €42,966 | +€13,555 | +46.1% |
| Other amounts receivable | 41 | €74,051 | €0 | -€74,051 | -100.0% |
| Cash at bank and in hand | 54/58 | €20,530 | €27,493 | +€6,963 | +33.9% |
| Deferred charges and accrued income | 490/1 | €581 | €624 | +€42 | +7.3% |
| Total equity and liabilities | 10/49 | €147,252 | €106,135 | -€41,118 | -27.9% |
| Equity | 10/15 | €29,990 | €29,522 | -€468 | -1.6% |
| Contributions | 10/11 | €20,460 | €20,460 | = | 0.0% |
| Profit (loss) carried forward | 14 | €9,530 | €9,062 | -€468 | -4.9% |
| Amounts payable | 17/49 | €117,262 | €76,613 | -€40,649 | -34.7% |
| Amounts payable after more than one year | 17 | €17,276 | €10,563 | -€6,713 | -38.9% |
| Financial debts | 170/4 | €17,276 | €10,563 | -€6,713 | -38.9% |
| Amounts payable within one year | 42/48 | €99,987 | €65,861 | -€34,126 | -34.1% |
| Current portion of amounts payable after more than one year | 42 | €6,461 | €12,641 | +€6,180 | +95.7% |
| Trade debts | 44 | €3,896 | €2,583 | -€1,313 | -33.7% |
| Suppliers | 440/4 | €3,896 | €2,583 | -€1,313 | -33.7% |
| Taxes, remuneration and social security | 45 | €5,450 | €11,572 | +€6,123 | +112.3% |
| Taxes | 450/3 | €5,450 | €11,572 | +€6,123 | +112.3% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €84,181 | €39,065 | -€45,116 | -53.6% |
| Accrued charges and deferred income | 492/3 | - | €189 | +€189 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,740 | €10,974 | +€1,234 | +12.7% |
| Other operating charges | 640/8 | €2,346 | €621 | -€1,725 | -73.5% |
| Gross operating margin | 9900 | €27,063 | €38,513 | +€11,450 | +42.3% |
| Operating profit (loss) | 9901 | €14,977 | €26,918 | +€11,940 | +79.7% |
| Financial income | 75/76B | €15 | €0 | -€15 | -100.0% |
| Recurring financial income | 75 | €15 | €0 | -€15 | -100.0% |
| Financial charges | 65/66B | €1,381 | €1,470 | +€89 | +6.5% |
| Recurring financial charges | 65 | €1,381 | €1,470 | +€89 | +6.5% |
| Profit (loss) for the period before taxes | 9903 | €13,612 | €25,448 | +€11,836 | +87.0% |
| Income taxes | 67/77 | €3,509 | €5,916 | +€2,407 | +68.6% |
| Profit (loss) for the period | 9904 | €10,102 | €19,532 | +€9,429 | +93.3% |
| Profit (loss) for the period to be appropriated | 9905 | €10,102 | €19,532 | +€9,429 | +93.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.